Filing Details
- Accession Number:
- 0000950170-24-130728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 21:30:07
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-25 21:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712601 | B. Steven Binder | 1 Casper Street Danbury CT 06810 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2024-11-22 | 67,536 | $1.47 | 1,142,562 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2024-11-22 | 67,536 | $6.89 | 1,075,026 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Employee Stock Option (Right to Buy) | Disposition | 2024-11-22 | 22,512 | $0.00 | 22,512 | $1.47 |
| Common Stock, $0.01 Par Value | Employee Stock Option (Right to Buy) | Disposition | 2024-11-22 | 22,512 | $0.00 | 22,512 | $1.47 |
| Common Stock, $0.01 Par Value | Employee Stock Option (Right to Buy) | Disposition | 2024-11-22 | 22,512 | $0.00 | 22,512 | $1.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-08-02 | 2027-08-24 | No | 4 | M | Direct |
| 0 | 2020-02-25 | 2027-08-24 | No | 4 | M | Direct |
| 0 | 2023-08-07 | 2027-08-24 | No | 4 | M | Direct |
Footnotes
- Transaction occurred pursuant to Rule 10b5-1 Plan established August 16, 2024.
- The weighted average sales price of the reported transaction was $6.89 based on a range of prices between $6.83 and $6.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Billionaire Hedge Funds
